ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or Ill estrogen receptor-positive HER2-negative breast cancer (ER+HER2-BC) in postmenopausal (PM) women: Alliance A011106 Meeting Abstract


Authors: Ma, C. X.; Suman, V. J.; Leitch, A. M.; Sanati, S.; Vij, K. R.; Unzeitig, G. W.; Hoog, J.; Watson, M.; Hahn, O. M.; Guenther, J. M.; Caudle, A. S.; Dockter, T.; Korde, L. A.; Weiss, A.; Hunt, K.; Hudis, C. A.; Winer, E. P.; Partridge, A. H.; Carey, L. A.; Ellis, M. J.; Alliance
Abstract Title: ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or Ill estrogen receptor-positive HER2-negative breast cancer (ER+HER2-BC) in postmenopausal (PM) women: Alliance A011106
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual Conference
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368300015
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.504
Notes: Meeting Abstract: 504 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis